To assess whether RGS17 gene deletion in hair cells protects against cisplatin-induced hearing loss, we performed a functional study comparing wild-type mice with inducible hair cell-specific RGS17 knockdown (RGS17+/−) and knockout (RGS17−/−) mice. The gene discussed is RGS17; the disease is hearing loss disorder.